COVID-19 vaccination in Peru
![]() | This article may be expanded with text translated from the corresponding article in Spanish. (April 2021) Click [show] for important translation instructions.
|
Date | 9 February 2021 |
---|---|
Location | Peru |
Cause | COVID-19 pandemic |
Target | Immunisation of peruvians against COVID-19 |
Organised by | Ministry of Health of Peru |
Website | www |
The COVID-19 vaccination program in Peru is the national vaccination strategy to protect the population against SARS-CoV-2 employing vaccines developed for COVID-19 pandemic. Vaccination began on 9 February 2021, after three days of arrival of first vaccines.[1] On a nation message, the head of state Francisco Sagasti confirmed the purchase of 38 millions of vaccines, being one million of vaccines for health personnel.[2]
Part of a series on the |
COVID-19 pandemic |
---|
|
![]() |
Timeline[edit]
Arrival of the first vaccines[edit]
On 7 February 2021 at 19:54 h (UTC-5), 300,000 vaccines lot of the Sinopharm enterprise coming from China arrived at the airport Jorge Chávez.[3] This event was overseen by the president, Francisco Sagasti. Shortly after, the head of state reported that on 14 February a remaining lot 700,000 vaccines will also arrive to the country.[4] On 8 February 2021, a thousand police officers were reported to guard the warehouse of National Center for the Supply of Strategic Health Resources (CENARES, acronym in Spanish).[5]
Vaccine distribution[edit]
According to the Government of Peru, the vaccination is predicted in three phases.[6]
Stage | People included |
---|---|
1 |
|
2 |
|
3 |
|
Public opinion[edit]
According to the study presented by IPSOS, a French sociological and market research company, the acceptance of the vaccine in the Peruvian population was below 50% until January 2021 due to an environment of mistrust in the management of the Vaccination and management of the pandemic during the government of Martín Vizcarra and Francisco Sagasti. As of February 2021, the period that begins the vaccination process, the study revealed a slow and steady increase in the acceptance of the COVID-19 vaccine.
Option Month
|
I do want to get vaccinated | I don't want to get vaccinated | I already got vaccinated | Not precise | Source |
---|---|---|---|---|---|
Aug 2020* | 75% | 22% | 0% | 3% | [7] |
Dec 2020* | 57% | 40% | 0% | 3% | [8] |
Jan 2021* | 48% | 48% | 0% | 4% | [9] |
Feb 2021* | 59% | 35% | 0% | 6% | [10] |
Mar 2021** | 60% | 33% | 0% | 7% | [11] |
May 2021 | 63% | 30% | 4% | 3% | [12] |
Note: (*) It was asked how “If right now a vaccine approved by the Ministry of Health and free to prevent the COVID-19, do you? would you be vaccinated or not vaccinated?
Note 2: (**) He wondered how “If tomorrow it's your turn for the COVID-19 vaccine, would you or would you not get the vaccine?"
Vaccines on order[edit]
Vaccine name | Progress | Quantity | Approval | Deployment | Last delivery |
---|---|---|---|---|---|
BBIBP-CorV–Sinopharm | Phase III clinical trials | 38 million | ![]() |
![]() |
13 February 2021 |
Pfizer–BioNTech | Phase III clinical trials | 20.5 million | ![]() |
![]() |
7 May 2021 |
12 million | ![]() | ||||
Oxford-AstraZeneca and Pfizer–BioNTech (by Covax Facility) | Phase III clinical trials | 13,2 million | ![]() |
![]() |
18 April 2021 |
Oxford-AstraZeneca | Phase III clinical trials | 14 million | ![]() |
![]() |
Not yet |
No. | Vaccine name | Quantity | Arrival date | Source(s) |
---|---|---|---|---|
1 | BBIBP-CorV–Sinopharm | 300,000 | 7 February 2021 | [14] |
2 | BBIBP-CorV–Sinopharm | 700,000 | 13 February 2021 | [23] |
3 | Pfizer–BioNTech | 50,000 | 3 March 2021 | [17] |
4 | Pfizer–BioNTech (by Covax Facility) | 117,000 | 10 March 2021 | [21] |
5 | Pfizer–BioNTech | 50,000 | 10 March 2021 | [21] [24] |
6 | Pfizer–BioNTech | 50,000 | 17 March 2021 | [25] |
7 | Pfizer–BioNTech | 50,310 | 24 March 2021 | [26] |
8 | Pfizer–BioNTech | 49,140 | 31 March 2021 | [27] |
9 | Pfizer–BioNTech | 200,070 | 7 April 2021 | [28] |
10 | Pfizer–BioNTech | 200,700 | 14 April 2021 | [29] |
11 | Oxford-AstraZeneca (by Covax Facility) | 276,000 | 18 April 2021 | [30] |
12 | Pfizer–BioNTech | 200,700 | 21 April 2021 | [31] |
13 | Pfizer–BioNTech | 200,000 | 28 April 2021 | [32] |
14 | Pfizer–BioNTech | 350,000 | 6 May 2021 | [33] |
15 | Pfizer–BioNTech | 350,000 | 7 May 2021 | [34] |
16 | Pfizer-BioNTech | 700,000 | 13 May 2021 | [16] |
Vaccine name | Quantity | Total | % de pop. | Target population[35] | % de pop. | Population (est. 2020)[36] |
---|---|---|---|---|---|---|
Sinopharm | 1,000,000 | 4,239,420 | 19.08% | 22,219,037 | 12.99% | 32,625,948 |
Pfizer-BioNTech | 2,963,420 | |||||
AstraZeneca | 276,000 |
Vaccines in trial stage[edit]
Vaccine | Type (technology) | Phase I | Phase II | Phase III |
---|---|---|---|---|
BBIBP-CorV | Inactivated | ![]() |
![]() |
![]() |
BNT162b2 | RNA | ![]() |
![]() |
![]() |
AZD1222 | Viral vector | ![]() |
![]() |
![]() |
Johnson & Johnson COVID-19 vaccine | Viral vector | ![]() |
![]() |
In progress |
CVnCoV | RNA | ![]() |
![]() |
In progress |
Statistics[edit]
By department[edit]
Department and autonomous province |
First dose | Second dose | Cumulative dose |
Population (est. 2020)[36] | ||
---|---|---|---|---|---|---|
Total | % of pop. | Total | % of pop. | |||
![]() |
3,625,355 | 11.11% | 2,044,193 | 6.27% | 5,669,548 | 32,625,948 |
![]() |
32,442 | 7.60% | 16,660 | 3.90% | 49,102 | 426,806 |
![]() |
117,162 | 9.92% | 70,395 | 5.96% | 187,557 | 1,180,638 |
![]() |
43,508 | 10.10% | 26,387 | 6.13% | 69,895 | 430,736 |
![]() |
182,473 | 12.19% | 78,382 | 5.23% | 260,855 | 1,497,438 |
![]() |
62,945 | 9.42% | 32,256 | 4.83% | 95,201 | 668,213 |
![]() |
101,672 | 6.99% | 50,305 | 3.46% | 151,977 | 1,453,711 |
![]() |
199,054 | 17.62% | 135,697 | 12.01% | 334,751 | 1,129,854 |
![]() |
99,485 | 7.33% | 39,940 | 2.94% | 139,425 | 1,357,075 |
![]() |
40,124 | 10.98% | 28,373 | 7.77% | 68,497 | 365,317 |
![]() |
56,539 | 7.44% | 28,075 | 3.69% | 84,614 | 760,267 |
![]() |
112,541 | 11.54% | 72,132 | 7.40% | 184,673 | 975,182 |
![]() |
145,751 | 10.71% | 56,114 | 4.12% | 201,865 | 1,361,467 |
![]() |
235,306 | 11.67% | 133,534 | 6.62% | 368,840 | 2,016,771 |
![]() |
149,094 | 11.37% | 67,549 | 5.15% | 216,643 | 1,310,785 |
![]() |
104,773 | 10.99% | 52,434 | 5.50% | 157,207 | 953,715 |
![]() |
1,413,399 | 14.61% | 879,933 | 9.10% | 2,293,332 | 9,674,755 |
![]() |
58,393 | 5.68% | 31,252 | 3.04% | 89,645 | 1,027,559 |
![]() |
10,321 | 5.94% | 4,801 | 2.76% | 15,122 | 173,811 |
![]() |
25,822 | 13.40% | 12,639 | 6.56% | 38,461 | 192,740 |
![]() |
21,291 | 7.83% | 11,555 | 4.25% | 32,846 | 271,904 |
![]() |
157,076 | 7.67% | 78,009 | 3.81% | 235,085 | 2,047,954 |
![]() |
75,273 | 6.08% | 33,639 | 2.72% | 108,912 | 1,237,997 |
![]() |
61,498 | 6.84% | 41,693 | 4.63% | 103,191 | 899,648 |
![]() |
63,561 | 17.13% | 24,690 | 6.66% | 88,251 | 370,974 |
![]() |
25,492 | 10.14% | 13,474 | 5.36% | 38,966 | 251,521 |
![]() |
30,360 | 5.15% | 24,275 | 4.12% | 54,635 | 589,110 |
Progress of the vaccination campaign[edit]
COVID-19 vaccination progress in Peru[37] Estimated population to be vaccinated: 22,219,037 people[38]
(Inoculated with first dose)
(Inoculated with second dose) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | First dose | Variation | % de pop. | Second dose | Variation | % de pop. | Total dose | ||||||||
9-feb-21 | 3,842 | 3,842 | 0.02% | 0 | 0 | 0.00% | 3,842 | ||||||||
15-feb-21 | 122,335 | 118,493 | 0.55% | 0 | 0 | 0.00% | 122,335 | ||||||||
1-mar-21 | 328,374 | 206,039 | 1.48% | 0 | 0 | 0.00% | 328,374 | ||||||||
15-mar-21 | 445,775 | 117,401 | 2.01% | 196,218 | 196,218 | 0.88% | 641,993 | ||||||||
1-apr-21 | 661,608 | 215,833 | 2.98% | 373,750 | 177,532 | 1.68% | 1,035,358 | ||||||||
15-abr-21 | 740,761 | 79,153 | 3.33% | 556,295 | 182,545 | 2.50% | 1,297,056 | ||||||||
1-may-21 | 1,185,933 | 445,172 | 5.34% | 678,125 | 121,830 | 3.05% | 1,864,058 | ||||||||
15-may-21 | 1,859,786 | 673,853 | 8.37% | 832,921 | 154,796 | 3.75% | 2,692,707 | ||||||||
1-jun-21 | 3,004,634 | 1,144,848 | 13.52% | 1,320,612 | 487,691 | 5.94% | 4,325,246 | ||||||||
15-jun-21 | 3,625,355 | 620,721 | 16.32% | 2,044,193 | 723,581 | 9.20% | 5,669,548 |
Demographics[edit]
Year group | Male | Female | First dose | Second dose | Cumulative dose |
Population (est. 2020)[40] | ||||
---|---|---|---|---|---|---|---|---|---|---|
One dose | Two dose | One dose | Two dose | Total | % of pop. | Total | % of pop. | |||
Total | 1,725,024 | 966,011 | 1,900,331 | 1,078,182 | 3,625,355 | 11.11% | 2,044,193 | 6.27% | 5,669,548 | 32,625,948 |
0-9 | 0 | 0 | 0 | 0 | 0 | 0.00% | 0 | 0.00% | 0 | 5,384,070 |
10-19 | 13,071 | 10,481 | 3,071 | 1,902 | 16,142 | 0.31% | 12,383 | 0.24% | 28,525 | 5,206,372 |
20-29 | 113,189 | 85,389 | 89,954 | 70,343 | 203,143 | 3.76% | 155,732 | 2.88% | 358,875 | 5,403,670 |
30-39 | 101,675 | 81,347 | 126,396 | 105,252 | 228,071 | 4.53% | 186,599 | 3.71% | 414,670 | 5,031,117 |
40-49 | 77,224 | 63,594 | 88,201 | 72,769 | 165,425 | 3.95% | 136,363 | 3.26% | 301,788 | 4,183,147 |
50-59 | 89,839 | 55,723 | 83,898 | 47,031 | 173,737 | 5.30% | 102,754 | 3.14% | 276,491 | 3,277,134 |
60-69 | 641,578 | 152,999 | 708,396 | 175,776 | 1,349,974 | 60.78% | 328,775 | 14.80% | 1,678,749 | 2,221,241 |
70-79 | 438,504 | 326,332 | 483,121 | 361,884 | 921,625 | 72.46% | 688,216 | 54.11% | 1,609,841 | 1,271,842 |
80+ | 186,883 | 154,424 | 243,912 | 202,010 | 430,795 | 66.55% | 356,434 | 55.06% | 787,229 | 647,355 |
No data | 63,061 | 35,722 | 73,382 | 41,215 | 136,443 | - | 76,937 | - | 213,380 | - |
Graphs[edit]
Departments by type of vaccines[edit]
- Last updated: June 15, 2021.
Source: Platform of "Datos abiertos", Government of Peru.[39]
Inoculated doses in provinces[edit]
- Last updated: June 15, 2021.
Percentage of population (2020) with second dose in most populated provinces of the country.
Note: Name of provinces and department name in parentheses. Chiclayo (Lambayeque), Coronel Portillo (Ucayali), Huancayo (Junin), Lima (Lima province), Maynas (Loreto), Santa (Ancash) and Trujillo (La Libertad)
Source: Platform of "Datos abiertos", Government of Peru.[39]
Inoculated doses in the districts of Lima[edit]
- Last updated: June 15, 2021.
Source: Platform of "Datos abiertos", Government of Peru.[39]
Vaccine distribution[edit]
- Last updated: June 15, 2021.
Source: Platform of "Datos abiertos", Government of Peru.[39]
Vaccination progress[edit]
- Last updated: June 15, 2021.
Source: Platform of "Datos abiertos", Government of Peru.[39]
References[edit]
- ^ "#Covid19Hoy: empieza la vacunación en Perú mientras avanza la segunda ola de contagios". www.france24.com (in Spanish). 10 February 2021. Retrieved 22 February 2021.
- ^ "Ahora Sagasti dice que el millón de dosis de la vacuna de Sinopharm llegará al Perú "en los próximos días"". gestion.pe (in Spanish). 26 January 2021. Retrieved 22 February 2021.
- ^ "Vacunas COVID-19 en Perú: mira aquí en vivo la llegada del primer lote con 300 mil dosis". peru21.pe (in Spanish). 7 February 2021. Retrieved 22 February 2021.
- ^ "Vacuna COVID-19 llegó al Perú: últimas noticias tras arribo de las dosis de Sinopharm al país". elcomercio.pe (in Spanish). 8 February 2021. Retrieved 22 February 2021.
- ^ "Primer lote de vacunas de Sinopharm permanece en almacén del Cenares". diariocorreo.pe (in Spanish). 8 February 2021. Retrieved 22 February 2021.
- ^ "MINSA ¿Quiénes serán vacunados?". www.minsa.gob.pe (in Spanish). Retrieved 22 February 2021.
- ^ "Encuesta Nacional Urbana Agosto 2020 - Vacuna y mitos" (PDF). www.ipsos.com (in Spanish). Retrieved 13 June 2021.
- ^ "Opinion Data - Diciembre 2020" (PDF). www.ipsos.com (in Spanish). 21 December 2020. Retrieved 13 June 2021.
- ^ "Encuesta de opinión urbana- rural de enero del 2021 de El Comercio - Ipsos" (PDF). www.ipsos.com (in Spanish). 17 January 2021. Retrieved 13 June 2021.
- ^ "Encuesta de opinión urbana- rural de febrero del 2021 de El Comercio - Ipsos" (PDF). www.ipsos.com (in Spanish). 14 February 2021. Retrieved 13 June 2021.
- ^ "Encuesta de opinión urbana- rural de marzo del 2021 de El Comercio - Ipsos" (PDF). www.ipsos.com (in Spanish). 17 March 2021. Retrieved 13 June 2021.
- ^ "Encuesta de opinión urbana- rural de mayo del 2021 de El Comercio - Ipsos" (PDF). www.ipsos.com (in Spanish). 18 May 2021. Retrieved 13 June 2021.
- ^ "Presidente Sagasti: Un millón de vacunas contra el covid-19 de Sinopharm llegarán este mes". elperuano.pe (in Spanish). 6 January 2021. Retrieved 22 February 2021.
- ^ a b "COVID-19: Primer lote de 300 mil vacunas de Sinopharm llegó al Perú". canaln.pe (in Spanish). 7 February 2021. Retrieved 5 March 2021.
- ^ "Gobierno firma contrato por 20 millones de dosis con laboratorio Pfizer". elperuano.pe (in Spanish). 9 February 2021. Retrieved 5 March 2021.
- ^ a b "Llega al Perú nuevo lote de 700 mil dosis de vacunas Pfizer". elperuano.pe (in Spanish). Retrieved 2021-05-17.
- ^ a b "Hoy llegan a Perú el primer lote de 50,000 vacunas de Pfizer contra el COVID-19". gestion.pe (in Spanish). 3 March 2021. Retrieved 5 March 2021.
- ^ "Francisco Sagasti: "Hemos cerrado un nuevo contrato con Pfizer por 12 millones de dosis adicionales"". elcomercio.pe (in Spanish). 6 May 2021. Retrieved 10 May 2021.
- ^ "El Perú accederá a más de 13 millones de dosis de vacunas contra la Covid-19 mediante el Mecanismo Covax Facility". www.gob.pe (in Spanish). 19 September 2020. Retrieved 16 May 2021.
- ^ "Vacuna contra COVID-19: Perú recibirá 1.7 millones de dosis de AstraZeneca y Pfizer". canaln.pe (in Spanish). 3 February 2021. Retrieved 10 March 2021.
- ^ a b c "Hoy llegan a Perú el primer envío de 117,000 vacunas vía Covax Facility". gestion.pe (in Spanish). 10 March 2021. Retrieved 10 March 2021.
- ^ "Vacuna COVID-19: Perú llegó a acuerdo con Astrazeneca-Oxford para la compra de 14 millones de dosis". elcomercio.pe (in Spanish). 6 January 2021. Retrieved 5 March 2021.
- ^ "Segundo lote de 700,000 vacunas de Sinopharm llega hoy al Perú". andina.pe (in Spanish). 13 February 2021. Retrieved 5 March 2021.
- ^ "Perú recibirá el 10 de marzo 117.000 vacunas de Covax Facility". swissinfo.ch (in Spanish). 6 March 2021. Retrieved 9 May 2021.
- ^ "Vacuna de Pfizer: Llegó a Perú el tercer lote de 50 mil dosis". canaln.pe (in Spanish). 17 March 2021. Retrieved 17 March 2021.
- ^ "Vacuna COVID-19: aterrizó en suelo peruano el avión con nuevo lote de 50.310 dosis de Pfizer". elcomercio.pe (in Spanish). 24 March 2021. Retrieved 24 March 2021.
- ^ "Llegó a Perú recibió quinta remesa de vacunas de Pfizer y el total llega a 250,000 dosis". gestion.pe (in Spanish). 31 March 2021. Retrieved 9 May 2021.
- ^ "Perú recibió lote de 200.070 vacunas de Pfizer contra la Covid-19". rpp.pe (in Spanish). 7 April 2021. Retrieved 9 May 2021.
- ^ "Covid-19: Nuevo lote de 200,700 vacunas Pfizer llega al Perú". elperuano.pe (in Spanish). 14 April 2021. Retrieved 9 May 2021.
- ^ "Vacunación contra COVID-19: Lote de 276 mil vacunas de AstraZeneca llegó al Perú". canaln.pe (in Spanish). 18 April 2021. Retrieved 9 May 2021.
- ^ "Perú recibió lote de 200.700 vacunas de Pfizer y el número total llega a 850.000 por compra directa". elcomercio.pe (in Spanish). 21 April 2021. Retrieved 9 May 2021.
- ^ "Un nuevo lote de 200 000 dosis de vacuna de Pfizer llegó al Perú esta noche". rpp.pe (in Spanish). 28 April 2021. Retrieved 9 May 2021.
- ^ "Nuevo lote con 350 mil vacunas contra la COVID-19 de Pfizer llegó esta noche al país". rpp.pe (in Spanish). 6 May 2021. Retrieved 9 May 2021.
- ^ "Perú recibió 350,000 vacunas de Pfizer y sumó 1.7 millones de dosis vía compra directa". gestion.pe (in Spanish). 7 May 2021. Retrieved 9 May 2021.
- ^ "Minsa aprobó Plan Nacional de Vacunación para inmunizar a 22.2 millones de personas contra la COVID-19". www.gob.pe (in Spanish). 21 October 2020. Retrieved 18 May 2021.
- ^ a b INEI. "PERÚ:Estimaciones y proyecciones de población por departamento, provincia y distrito, 2018-2020" (PDF) (in Spanish).
- ^ a b "Plataforma de vacunación en tiempo real". gis.minsa.gob.pe (in Spanish). Retrieved 22 February 2021.
- ^ Ministry of Health of Peru (21 October 2020). "Minsa aprobó Plan Nacional de Vacunación para inmunizar a 22.2 millones de personas contra la COVID-19" (HTML) (in Spanish). Retrieved 19 May 2021.
- ^ a b c d e f "Vacunación contra COVID - 19 - [Ministerio de Salud - MINSA]". datosabiertos.gob.pe (in Spanish). Retrieved 14 March 2021.
- ^ MINSA. "Estadística poblacional" (ASP) (in Spanish).